All News
Filter News
Found 808,606 articles
-
TherOx Receives FDA Approval for First Heart Attack Treatment Since PCI to Reduce Infarct Size
4/4/2019
SuperSaturated Oxygen (SSO2) Therapy treats damaged heart tissue with hyperbaric levels of oxygen during a single catheter-delivered infusion
-
Renown Health and Genome Medical Partner to Bring Genetic Counseling and Educational Services to Patients for End-to-End Genetic Testing Support
4/4/2019
Renown Health, northern Nevada's healthcare leader and Reno's only locally owned not-for-profit health system, and Genome Medical, a leading nationwide telegenomics technology and services company, today announced a partnership to bring genetic counseling and educational services to participants of the Healthy Nevada Project.
-
MYOS RENS Technology Signs Distribution Agreement with National Sales Associates, LLC
4/4/2019
Yolked® and MYOS Canine Muscle Formula® to be Distributed Nationwide
-
Greenphire Launches New Tax Capability to Ease Administrative Burden and Improve Compliance for Clinical Trial Industry
4/4/2019
New feature helps clinical trial research sites and sponsors more accurately and efficiently achieve IRS tax compliance while maintaining confidentiality and privacy
-
Velocity Urgent Care Leader To Receive National Recognition
4/4/2019
Alan Ayers to receive Urgent Care Association's Lifetime Membership Award
-
At-plant nematode control increases cotton yield potential
4/4/2019
University trials across the South show that cotton growers who are battling nematodes can increase their yield and profit with an at-plant nematicide application.
-
Seisa Medical Announces Acquisition of Burpee MedSystems
4/4/2019
Seisa Medical Inc., a full-service provider of integrated manufacturing and development services to the medical device industry, today announced that it has acquired Burpee MedSystems LLC, a leading manufacturer of stents and delivery devices.
-
DocuSol® Kids Mini-Enemas Used for Constipation Related to Childhood Bathroom Avoidance
4/4/2019
DocuSol® Kids mini-enemas are often used by parents dealing with children who routinely avoid using the bathroom and become constipated.
-
Make-A-Wish® Receives Record Total Donation from Subaru Share the Love® Event
4/4/2019
Subaru donates more than $3.6 million to help grant life-changing wishes for children with critical illnesses
-
April is Oral Cancer Awareness Month: Self-exams, early detection can save lives
4/4/2019
Because early detection of oral cancer offers a greater chance of a cure, the American Association of Oral and Maxillofacial Surgeons is reminding the public during Oral Cancer Awareness Month of the importance of performing monthly self-exams.
-
CooperVision Rochester-Area Sites Now Operating with 100 Percent Renewable Electricity Resources
4/4/2019
Taking yet another step to succeed with sustainability in mind, CooperVision has converted its three Rochester, N.Y.-area sites to 100 percent renewable electricity usage
-
Transaction Data Systems (TDS) Announces Acquisition of Pharm Assess, Inc.
4/4/2019
Transaction Data Systems (TDS), parent company of the Rx30 and Computer-Rx pharmacy management systems, today publicly announced the acquisition of Pharm Assess, Inc. and its Retail Business Solutions product suite (RBS).
-
Cyanotech® Corporation Earns Blue Zones® Certification
4/4/2019
Cyanotech Corporation,, a world leader in microalgae-based, high-value nutrition and health products, is proud to announce that it has joined the Blue Zones Project ‘Ohana.
-
Daiichi Sankyo Provides Update on Ongoing FDA Review for Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
4/4/2019
Daiichi Sankyo Company, Limited announced that the U.S. Food and Drug Administration has extended the review period for the New Drug Application of quizartinib, an investigational FLT3 inhibitor, currently under Priority Review for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia.
-
New $22 Million Project Targets Deadly Viruses
4/4/2019
Five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.
-
Tioga Medical, A Shifamed Portfolio Company, Closes $15M In Series A Financing
4/4/2019
Company is developing a novel transcatheter valve replacement technology for mitral and tricuspid applications
-
Ikonopedia to Introduce Automated Combined Reporting Package at SBI
4/4/2019
Ikonopedia, Inc., pioneers of a patented Cloud-based structured breast reporting system, will introduce its new Automated Combined Reporting package here, at the 2019 SBI/ACR Breast Imaging Symposium, April 4-7, 2019 (Booth #302).
-
MYR Pharmaceuticals Announces Presentation of Final Results of the MYR203 Study of bulevirtide (Myrcludex) at the International Liver Congress (ILC) 2019 in Vienna.
4/4/2019
MYR Pharmaceuticals today announced that the final results of the MYR203 study of bulevirtide (Myrcludex), MYR's first-in-class entry inhibitor for treatment of hepatitis B and D infection, will be presented at the General Session of the upcoming 2019 ILC meeting in Vienna
-
Citius Pharmaceuticals Successfully Raises $5.3 Million
4/4/2019
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that the Company completed an at-the-market offering for $5.3 million in gross proceeds, with insiders responsible for supporting over 37% of the raise.
-
Track 60,000 Medical Coverage Policies in 5 Minutes - Reimbursement Tracker for the U.S.
4/4/2019
The reimbursement environment in the United States is complex, with hundreds of insurers and tens of thousands of policies.